Cargando…
Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
INTRODUCTION: The skin is a vital organ as the body’s largest barrier, but its function declines with aging. Therefore, research into effective regeneration treatments must continue to advance. Stem cell transplantation, a cell-based therapy, has become a popular skin-aging treatment, although it co...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676866/ https://www.ncbi.nlm.nih.gov/pubmed/38021432 http://dx.doi.org/10.2147/CCID.S434439 |
_version_ | 1785149995339481088 |
---|---|
author | Chou, Yoan Alfarafisa, Nayla Majeda Ikezawa, Maiko Khairani, Astrid Feinisa |
author_facet | Chou, Yoan Alfarafisa, Nayla Majeda Ikezawa, Maiko Khairani, Astrid Feinisa |
author_sort | Chou, Yoan |
collection | PubMed |
description | INTRODUCTION: The skin is a vital organ as the body’s largest barrier, but its function declines with aging. Therefore, research into effective regeneration treatments must continue to advance. Stem cell transplantation, a cell-based therapy, has become a popular skin-aging treatment, although it comes with drawbacks like host immune reactions. Stem cell-derived cell-free therapies have emerged as an alternative, backed by promising preclinical findings. Stem cell secretomes and extracellular vesicles (EVs) are the key components in cell-free therapy from stem cells. However, comprehensive reviews on the mechanisms of such treatments for skin aging are still limited. PURPOSE: This review discusses stem cell-derived cell-free therapy’s potential mechanisms of action related to skin aging prevention by identifying specific molecular targets suitable for the interventions. METHODS: A search identified 27 relevant in vitro studies on stem cell-derived cell-free therapy interventions in skin aging model cells without restricting publication years using PubMed, Scopus, and Google Scholar. RESULTS: Stem cell-derived cell-free therapy can prevent skin aging through various mechanisms, such as (1) involvement of multiple regenerative pathways [NFkb, AP-1, MAPK, P-AKT, NRF2, SIRT-1]; (2) oxidative stress regulation [by reducing oxidants (HO-1, NQO1) and enhancing antioxidants (SOD1, CAT, GP, FRAP)]; (3) preventing ECM degradation [by increasing elastin, collagen, HA, TIMP, and reducing MMP]; (4) regulating cell activity [by reducing cell senescence (SA-β-gal), apoptosis, and cell cycle arrest (P53, P12, P16); and enhancing autophagy, cell migration, and cell proliferation (Ki67)] (5) Regulating the inflammatory pathway [by reducing IL-6, IL-1, TNF-⍺, and increasing TGF-β]. Several clinical trials have also revealed improvements in wrinkles, elasticity, hydration, pores, and pigmentation. CONCLUSION: Stem cell-derived cell-free therapy is a potential novel treatment for skin aging by cell rejuvenation through various molecular mechanisms. |
format | Online Article Text |
id | pubmed-10676866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106768662023-11-22 Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging Chou, Yoan Alfarafisa, Nayla Majeda Ikezawa, Maiko Khairani, Astrid Feinisa Clin Cosmet Investig Dermatol Review INTRODUCTION: The skin is a vital organ as the body’s largest barrier, but its function declines with aging. Therefore, research into effective regeneration treatments must continue to advance. Stem cell transplantation, a cell-based therapy, has become a popular skin-aging treatment, although it comes with drawbacks like host immune reactions. Stem cell-derived cell-free therapies have emerged as an alternative, backed by promising preclinical findings. Stem cell secretomes and extracellular vesicles (EVs) are the key components in cell-free therapy from stem cells. However, comprehensive reviews on the mechanisms of such treatments for skin aging are still limited. PURPOSE: This review discusses stem cell-derived cell-free therapy’s potential mechanisms of action related to skin aging prevention by identifying specific molecular targets suitable for the interventions. METHODS: A search identified 27 relevant in vitro studies on stem cell-derived cell-free therapy interventions in skin aging model cells without restricting publication years using PubMed, Scopus, and Google Scholar. RESULTS: Stem cell-derived cell-free therapy can prevent skin aging through various mechanisms, such as (1) involvement of multiple regenerative pathways [NFkb, AP-1, MAPK, P-AKT, NRF2, SIRT-1]; (2) oxidative stress regulation [by reducing oxidants (HO-1, NQO1) and enhancing antioxidants (SOD1, CAT, GP, FRAP)]; (3) preventing ECM degradation [by increasing elastin, collagen, HA, TIMP, and reducing MMP]; (4) regulating cell activity [by reducing cell senescence (SA-β-gal), apoptosis, and cell cycle arrest (P53, P12, P16); and enhancing autophagy, cell migration, and cell proliferation (Ki67)] (5) Regulating the inflammatory pathway [by reducing IL-6, IL-1, TNF-⍺, and increasing TGF-β]. Several clinical trials have also revealed improvements in wrinkles, elasticity, hydration, pores, and pigmentation. CONCLUSION: Stem cell-derived cell-free therapy is a potential novel treatment for skin aging by cell rejuvenation through various molecular mechanisms. Dove 2023-11-22 /pmc/articles/PMC10676866/ /pubmed/38021432 http://dx.doi.org/10.2147/CCID.S434439 Text en © 2023 Chou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Chou, Yoan Alfarafisa, Nayla Majeda Ikezawa, Maiko Khairani, Astrid Feinisa Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging |
title | Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging |
title_full | Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging |
title_fullStr | Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging |
title_full_unstemmed | Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging |
title_short | Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging |
title_sort | progress in the development of stem cell-derived cell-free therapies for skin aging |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676866/ https://www.ncbi.nlm.nih.gov/pubmed/38021432 http://dx.doi.org/10.2147/CCID.S434439 |
work_keys_str_mv | AT chouyoan progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging AT alfarafisanaylamajeda progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging AT ikezawamaiko progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging AT khairaniastridfeinisa progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging |